An Open Phase III Trial With Letrozole Alone or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer.

Trial Profile

An Open Phase III Trial With Letrozole Alone or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Oct 2011

At a glance

  • Drugs Letrozole; Zoledronic acid
  • Indications Breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EXpand
  • Sponsors Novartis
  • Most Recent Events

    • 27 Sep 2011 Results presented at the 2011 European Multidisciplinary Cancer Congress.
    • 17 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top